Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity

Our results imply that IL-23 may potentially play a role in the pathogenesis of RA and may be a useful biomarker for the diagnosis of this disease. Targeting the IL-23 cytokine may provide a new therapeutic approach in the treatment of RA.